Serum procalcitonin predicts development of acute kidney injury in patients with suspected infection

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 8, 2013, Pages 1655-1661

  Nie, Xin ^a   Wu, Bin ^a   He, Yong ^a   Huang, Xunbei ^a   Dai, Zhongqiu ^a   Miao, Qiang ^a   Song, Haolan ^a   Luo, Tongxing ^a   Gao, Baoxiu ^a   Wang, Lanlan ^a   Li, Guixing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

acute kidney injury; procalcitonin; receiver operating characteristic curve

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYSTATIN C; INTERLEUKIN 6; PROCALCITONIN; SERUM AMYLOID A; UREA;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; INFECTION; KIDNEY FUNCTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; THYROID HORMONE BLOOD LEVEL; UREA BLOOD LEVEL;

ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEPSIS; SHOCK, SEPTIC; YOUNG ADULT;

EID: 84882967892     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0822     Document Type: Article

References (39)

1. Bagshaw SM, Laupland KB, Doig CJ, Mortis G, Fick GH, Mucenski M, et al. Prognosis for long-Term survival and renal recovery in critically ill patients with severe acute renal failure: A population-based study. Crit Care 2005;9:R700-9
2. Korkeila M, Ruokonen E, Takala J. Costs of care, long-Term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med 2000;26:1824-31 (Pubitemid 32010000)
3. Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002;30:2051-8
4. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: A multinational, multicenter study. J Am Med Assoc 2005;294:813-8 (Pubitemid 41175724)
5. Bagshaw SM, George C, Bellomo R. Early acute kidney injury and sepsis: A multicentre evaluation. Crit Care 2008;12:R47
6. Zarjou A, Agarwal A. Sepsis and acute kidney injury. J Am Soc Nephrol 2011;22:999-1006
7. Murugan R, Kellum JA. Acute kidney injury: What s the prognosis? Nat Rev Nephrol 2011;7:209-17
8. Parmar A, Langenberg C, Wan L, May CN, Bellomo R, Bagshaw SM. Epidemiology of septic acute kidney injury. Curr Drug Targets 2009;10:1169-78
9. Oppert M, Engel C, Brunkhorst FM, Bogatsch H, Reinhart K, Frei U, et al. Acute renal failure in patients with severe sepsis and septic shock-A significant independent risk factor for mortality: Results from the German Prevalence Study. Nephrol Dial Transplant 2008;23:904-9 (Pubitemid 351767542)
10. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006;34:344-53 (Pubitemid 43145611)
11. Lopes JA, Jorge S, Resina C, Santos C, Pereira A, Neves J, et al. Acute renal failure in patients with sepsis. Crit Care 2007;11:411
12. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8 (Pubitemid 23066085)
13. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266
14. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int SUPPL2012;2:1-138
15. Hoste EA, Lameire NH, Vanholder RC, Benoit DD, Decruyenaere JM, Colardyn FA. Acute renal failure in patients with sepsis in a surgical ICU: Predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol 2003;14:1022-30 (Pubitemid 36359284)
16. Rau B, Steinbach G, Baumgart K, Gansauge F, Grunert A, Beger HG. The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis. Intensive Care Med 2000;26(Suppl 2):S159-64 (Pubitemid 30186575)
17. Yegenaga I, Hoste E, Van Biesen W, Vanholder R, Benoit D, Kantarci G, et al. Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: Results of a prospective study. Am J Kidney Dis 2004;43:817-24 (Pubitemid 38529619)
18. Leblanc M, Kellum JA, Gibney RT, Lieberthal W, Tumlin J, Mehta R. Risk factors for acute renal failure: Inherent and modifiable risks. Curr Opin Crit Care 2005;11:533-6 (Pubitemid 41697323)
19. Cardelli P, Ferraironi M, Amodeo R, Tabacco F, De Blasi RA, Nicoletti M, et al. Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis. Int J Immunopathol Pharmacol 2008;21:43-9 (Pubitemid 351501000)
20. Lannergard A, Larsson A, Friman G, Ewald U. Human serum amyloid A (SAA) and high sensitive C-reactive protein (hsCRP) in preterm newborn infants with nosocomial infections. Acta Paediatr 2008;97:1061-5
21. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations. Crit Care Med 2008;36:941-52
22. Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, Vincent JL. Procalcitonin levels in surgical patients at risk of candidemia. J Infect 2010;60:425-30
23. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial. Lancet 2010;375:463-74
24. Enguix A, Rey C, Concha A, Medina A, Coto D, Dieguez MA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 2001;27:211-5 (Pubitemid 32208990)
25. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999;27:498-504 (Pubitemid 29162669)
26. Nakamura A, Wada H, Ikejiri M, Hatada T, Sakurai H, Matsushima Y, et al. Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit. Shock 2009;31:586-91
27. Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr TT, Andersen MH, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial. Crit Care Med 2011;39:2048-58
28. Deis JN, Creech CB, Estrada CM, Abramo TJ. Procalcitonin as a marker of severe bacterial infection in children in the emergency department. Pediatr Emerg Care 2010;26:51-60, 61-3
29. Chan T, Gu F. Early diagnosis of sepsis using serum biomarkers. Expert Rev Mol Diagn 2011;11:487-96
30. Bohnhorst B, Lange M, Bartels DB, Bejo L, Hoy L, Peter C. Procalcitonin and valuable clinical symptoms in the early detection of neonatal late-onset bacterial infection. Acta Paediatr 2012;101:19-25
31. Povoa P, Salluh JI. Biomarker-guided antibiotic therapy in adult critically ill patients: A critical review. Ann Intensive Care 2012;2:32
32. Makris K, Rizos D, Kafkas N, Haliassos A. Neurophil gelatinaseassociated lipocalin as a new biomarker in laboratory medicine. Clin Chem Lab Med 2012;50:1519-32
33. Lippi G, Plebani M. Neutrophil gelatinase-Associated lipocalin (NGAL): The laboratory perspective. Clin Chem Lab Med 2012;50:1483-7
34. Clerico A, Galli C, Fortunato A, Ronco C. Neutrophil gelatinaseassociated lipocalin (NGAL) as biomarker of acute kidney injury: A review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med 2012;50:1505-17
35. Devarajan P. Neutrophil gelatinase-Associated lipocalin-An emerging troponin for kidney injury. Nephrol Dial Transplant 2008;23:3737-43
36. Soni SS, Pophale R, Ronco C. New biomarkers for acute renal injury. Clin Chem Lab Med 2011;49:1257-63
37. Devarajan P. Review: Neutrophil gelatinase-Associated lipocalin: A troponin-like biomarker for human acute kidney injury. Nephrology (Carlton) 2010;15:419-28
38. Makris K, Markou N, Evodia E, Dimopoulou E, Drakopoulos I, Ntetsika K, et al. Urinary neutrophil gelatinase-Associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med 2009;47:79-82
39. Ertugrul S, Annagur A, Kurban S, Altunhan H, Ors R. Comparison of urinary neutrophil gelatinase-Associated lipocalin, C-reactive protein and procalcitonin in the diagnosis of late onset sepsis in preterm newborns. J Matern Fetal Neonatal Med 2013;26:430-3